Solesence, Inc. Common Stock Net Assets
Solesence, Inc. Common Stock net assets. Based on the latest financial reports, Solesence, Inc. Common Stock (SLSN) has net assets worth $29.66 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($47.79 Million) and total liabilities ($18.14 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore SLSN net assets growth trend to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $29.66 Million |
| % of Total Assets | 62.05% |
| Annual Growth Rate | 23.97% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 308.89 |
Net Assets of Solesence, Inc. Common Stock (2021–2025)
Net assets of Solesence, Inc. Common Stock from 2021 to 2025. This chart illustrates how Solesence, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. See how leveraged is Solesence, Inc. Common Stock's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for Solesence, Inc. Common Stock (2021–2025)
The table below shows the annual net assets of Solesence, Inc. Common Stock from 2021 to 2025. For live market cap and overall valuation, see SLSN market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $17.63 Million | +17.98% |
| 2024-12-31 | $14.95 Million | +685.80% |
| 2023-12-31 | $1.90 Million | -66.33% |
| 2022-12-31 | $5.65 Million | -24.33% |
| 2021-12-31 | $7.46 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Solesence, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 119100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Solesence, Inc. Common Stock Net Assets Breakdown (December 2025)
Solesence, Inc. Common Stock net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $706.00K | 4.00% |
| Other Components | $115.57 Million | 655.36% |
| Total Equity | $17.63 Million | 100.00% |
Solesence, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Solesence, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Gemfields Group Ltd
JSE:GML
|
$60.48 Million |
|
Sono-Tek Corp
NASDAQ:SOTK
|
$60.48 Million |
|
Enersense International Oyj
HE:ESENSE
|
$60.49 Million |
|
Sunmow Holding Bhd
KLSE:03050
|
$60.50 Million |
|
Cepatwawasan Group Bhd
KLSE:8982
|
$60.47 Million |
|
Arrienda Rental Properties SOCIMI SA
MC:YARP
|
$60.46 Million |
|
Halla Eng&Cons
KO:014790
|
$60.42 Million |
|
DP POLAND PLC
F:2OP
|
$60.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Solesence, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 14,946,000 to 17,634,000, a change of 2,688,000 (18.0%).
- Net income of 1,790,000 contributed positively to equity growth.
- Other factors increased equity by 898,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.79 Million | +10.15% |
| Other Changes | $898.00K | +5.09% |
| Total Change | $- | 17.98% |
Book Value vs Market Value Analysis
This analysis compares Solesence, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.52x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 5.39x to 3.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $0.16 | $0.86 | x |
| 2022-12-31 | $0.12 | $0.86 | x |
| 2023-12-31 | $0.04 | $0.86 | x |
| 2024-12-31 | $0.23 | $0.86 | x |
| 2025-12-31 | $0.24 | $0.86 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Solesence, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.15%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.88%
- • Asset Turnover: 1.24x
- • Equity Multiplier: 2.84x
- Recent ROE (10.15%) is above the historical average (-41.54%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 31.08% | 7.87% | 1.04x | 3.80x | $1.57 Million |
| 2022 | -46.43% | -7.03% | 1.11x | 5.94x | $-3.19 Million |
| 2023 | -230.81% | -11.77% | 1.13x | 17.29x | $-4.58 Million |
| 2024 | 28.34% | 8.09% | 1.05x | 3.35x | $2.74 Million |
| 2025 | 10.15% | 2.88% | 1.24x | 2.84x | $26.60K |
Industry Comparison
This section compares Solesence, Inc. Common Stock's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $756,564,955
- Average return on equity (ROE) among peers: -30.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Solesence, Inc. Common Stock (SLSN) | $29.66 Million | 31.08% | 0.61x | $60.47 Million |
| Acme United Corporation (ACU) | $52.33 Million | 8.79% | 1.09x | $158.51 Million |
| Instinct Bio Technical Company Holdings Inc. Ordinary Shares (BIOT) | $2.34 Million | 3.19% | 0.33x | $5.34 Million |
| Bruush Oral Care Inc. (BRSHF) | $-1.40 Million | 0.00% | 0.00x | $20.19K |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $1.51 Million | 31.78% | 1.05x | $12.69 Million |
| Church & Dwight Company Inc (CHD) | $153.90 Million | 3.96% | 0.92x | $24.49 Billion |
| Colgate-Palmolive Company (CL) | $2.03 Billion | 31.22% | 2.88x | $74.35 Billion |
| The Clorox Company (CLX) | $1.79 Billion | 21.96% | 1.43x | $10.75 Billion |
| Coty Inc (COTY) | $3.56 Billion | 7.29% | 2.41x | $2.51 Billion |
| Carmell Therapeutics Corporation (CTCX) | $-29.58 Million | 0.00% | 0.00x | $4.61 Million |
| Big Tree Cloud Holdings Limited Ordinary Shares (DSY) | $453.17K | -417.72% | 4.36x | $4.14 Million |
About Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingre… Read more